- Report
- November 2022
- 20 Pages
United Kingdom
From €2858EUR$2,995USD£2,395GBP
- Report
- November 2022
- 20 Pages
United States
From €2858EUR$2,995USD£2,395GBP
- Book
- March 2025
- 472 Pages
- Report
- May 2022
- 284 Pages
Global
From €3298EUR$3,456USD£2,764GBP
- Report
- March 2022
- 180 Pages
Global
From €3407EUR$3,570USD£2,855GBP
- Report
- November 2021
- 145 Pages
Global
From €3543EUR$3,712USD£2,968GBP
- Book
- December 2024
- 384 Pages
- Book
- April 2023
- 1120 Pages
- Book
- January 2023
- 1072 Pages
- Book
- January 2020
- 816 Pages
- Book
- October 2023
- 1552 Pages
- Book
- January 2021
- 944 Pages
- Book
- April 2018
- 528 Pages
- Book
- April 2017
- 288 Pages
- Book
- May 2015
- 205 Pages
- Book
- January 2010
- 654 Pages

Cardiovascular surgery is a type of surgery that focuses on the heart and its surrounding blood vessels. It is used to treat a variety of conditions, including coronary artery disease, congenital heart defects, and valvular heart disease. Cardiovascular surgery is typically performed by a team of surgeons, cardiologists, and anesthesiologists. The procedure may involve open-heart surgery, minimally invasive surgery, or a combination of both.
The cardiovascular surgery market is a subset of the larger surgical procedures market. It is composed of a variety of products and services, including medical devices, implants, and pharmaceuticals. The market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures.
Some of the major companies in the cardiovascular surgery market include Medtronic, Johnson & Johnson, St. Jude Medical, Boston Scientific, and Abbott Laboratories. Show Less Read more